Product image of Lexomil (Bromazepam) supplied by GNH India

Lexomil

Active Ingredient:
Bromazepam
Origin:
EU

Lexomil (Bromazepam)

Bromazepam, the active ingredient in Lexomil, is a benzodiazepine presented as an oral dosage form for oral administration. It is prescribed for the management of anxiety disorders and for short‑term relief of anxiety symptoms in adult patients and can be used under medical supervision.

GNH India supplies Lexomil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory documentation and logistics support for bulk and unit‑dose requirements across multiple markets.

Manufacturer / TM Owner

Cheplapharm Arzneimittel Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Bromazepam is used within the benzodiazepine class to treat conditions characterized by heightened anxiety and related symptoms.

  • Anxiety disorders: reduces excessive worry and tension, helping patients achieve calmer daily functioning.
  • Short‑term relief of anxiety symptoms: provides rapid symptom control during acute stress episodes or before procedures.
  • Adjunctive sedation: enhances sedation when combined with other agents for pre‑operative or diagnostic settings.
  • Pre‑operative anxiety: helps calm patients before surgery, reducing peri‑operative stress.
  • Procedural sedation: used as part of a sedation regimen for minor diagnostic procedures.

How It Works

  • Bromazepam acts as a positive allosteric modulator at the γ‑aminobutyric acid type A (GABA‑A) receptor complex. By binding to the benzodiazepine site, it increases the affinity of GABA for its receptor, enhancing chloride ion influx and producing a greater inhibitory neuronal effect. This potentiation of GABAergic transmission leads to anxiolysis, sedation, muscle relaxation and anticonvulsant activity in the central nervous system.

Side Effects

Bromazepam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Drowsiness
  • Fatigue
  • Dizziness
  • Headache

Serious or Rare Side Effects

  • Respiratory depression
  • Paradoxical agitation
  • Allergic reactions such as rash or anaphylaxis

Precautions & Warnings

When prescribing bromazepam, clinicians should observe several safety precautions to minimize risks.

  • Assess renal and hepatic function: evaluate before initiating therapy and adjust if impairment exists.
  • Avoid abrupt discontinuation: taper the dose gradually to prevent withdrawal symptoms.
  • Use caution in elderly patients: start with the lowest effective dose due to increased sensitivity.
  • Contraindicate concurrent alcohol use: alcohol may potentiate central nervous system depression.
  • Monitor for dependence and abuse: regular review of usage patterns is recommended.
  • Store at ambient temperature: keep tablets in the original container, protect from moisture and light.

Avoid Interactions

Bromazepam can interact with other substances that affect the central nervous system or its metabolism.

Major Interactions (Avoid)

  • Opioids (e.g., morphine, oxycodone): combined use may cause profound respiratory depression.
  • Other benzodiazepines or sedative‑hypnotics: additive CNS depression increases risk of oversedation.
  • Alcohol: concurrent consumption enhances sedative effects and can be life‑threatening.

Moderate Interactions (Monitor Closely)

  • Antidepressants (SSRIs, SNRIs): may increase sedation; monitor patient response.
  • Antihistamines (e.g., diphenhydramine): can augment drowsiness and impair psychomotor performance.
  • CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise bromazepam plasma levels; dosage adjustment may be needed.

Frequently Asked Questions

Lexomil contains bromazepam, a benzodiazepine indicated for the management of anxiety disorders, short‑term relief of acute anxiety symptoms, and as an adjunct to sedation in pre‑operative or procedural settings. It helps reduce excessive worry, tension, and facilitates calmer patient experiences during stressful situations.

Bromazepam binds to the benzodiazepine site on the GABA‑A receptor complex, acting as a positive allosteric modulator. This increases GABA’s affinity for the receptor, leading to enhanced chloride influx, greater neuronal inhibition, and consequently produces anxiolytic, sedative, muscle‑relaxant, and anticonvulsant effects.

The appropriate dose of Lexomil is determined by the prescribing clinician based on the individual’s medical condition, age, response, and other medications. Dosage may be adjusted during treatment, and any changes should be made under professional supervision.

Bromazepam is generally not recommended for use during pregnancy or while breastfeeding because potential risks to the fetus or infant cannot be ruled out. Patients who are pregnant, planning pregnancy, or nursing should discuss alternative therapies with their healthcare provider.

To order Lexomil, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lexomil (bromazepam) is a benzodiazepine with a relatively rapid onset of action and a moderate half‑life, offering effective short‑term anxiety relief. Compared with agents such as diazepam, it has a shorter duration, which may reduce residual sedation, but it still shares the class‑related risk of dependence and withdrawal.

Lexomil tablets should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discoloured.

Lexomil is taken orally, usually with a glass of water. The tablet should be swallowed whole and not chewed or crushed unless otherwise directed by a healthcare professional. Administration timing (e.g., with or without food) follows the prescriber’s instructions.

Serious risks include respiratory depression, especially when combined with other central nervous system depressants, paradoxical reactions such as agitation or aggression, severe hypotension, and allergic responses ranging from rash to anaphylaxis. Immediate medical attention is required if any of these occur.

Lexomil should be avoided in individuals with known hypersensitivity to bromazepam or other benzodiazepines, those with severe respiratory insufficiency, acute narrow‑angle glaucoma, or severe hepatic impairment. It is also contraindicated in patients currently abusing alcohol or other depressant substances without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Bromazepam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT